Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T40879 |
7-MAD-MDCPT
|
||
7-MAD-MDCPT, a Camptothecin analog, is a toxin payload in antibody drug conjugates (ADCs). | |||
T39941 |
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT |
||
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a Camptothecin-linker. MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a drug-linker conjugate for antibody-drug conjugate (ADC). | |||
T72756 |
Gly-7-MAD-MDCPT
|
||
Gly-7-MAD-MDCPT 是一种抗癌剂。Gly-7-MAD-MDCPT 是一种喜树碱 (Camptothecin) 化合物,对多种癌细胞有细胞毒性,IC50为 10-1000 nM。 | |||
T74750 |
NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT
|
||
NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT(化合物I)作为一种拓扑异构酶I抑制剂,通过偶联抗体实现对细胞的靶向传递,展现出良好的体内外ADC活性。 | |||
T77873 |
NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT hydrochloride
|
Topoisomerase | DNA Damage/DNA Repair |
NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT(化合物I)盐酸盐是一种通过偶联抗体实现靶向细胞传递的拓扑异构酶I抑制剂,显示出优良的体内外ADC活性。 | |||
T81752 |
MP-PEG8-Val-Lys-Gly-7-MAD-MDCPT
|
||
MP-PEG8-Val-Lys-Gly-7-MAD-MDCPT为喜树碱-接头化合物,属于抗体偶联活性分子(drug-linker conjugate for ADC)部分。该化合物在癌症及自身免疫性疾病研究中显示出研究潜力。 | |||
T74751 | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT | ||
Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (Formula V),作为抗体偶联药物(ADC)的药物连接体部分,该化合物通过linker与topoisomeraseI抑制剂相连。 |